Imatinib and lung infiltration Patient Reports February 11, 2012

Imatinib Side Effects Report #4878548-5
Imatinib side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2006. Male patient, weighting 234.1 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: asthma , atelectasis, bone disorder, chest x-ray abnormal, disease progression, lung infiltration. Imatinib dosage: 400MG DAILY PO X 8 DAYS. During the same period patient was treated with TEMOZOLOMIDE, DECADRON, PROTONIX, TEGRETOL, POTASSIUM CHLORIDE, ALLEGRA, SINGULAIR, RITALIN. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5002201-0
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Female patient, weighting 132.9 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, cough, disease progression, dyspnoea, fatigue, lung infiltration, pneumocystis jiroveci pneumonia, pyrexia. Imatinib dosage: 400 MG DAILY PO. During the same period patient was treated with HYDREA, DEXAMETHASONE, PREVACID, AMBIEN, ALLEGRA, TOPROL. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #4675926-4
Imatinib side effect was reported by a Physician from on May 20, 2005. Female patient, 77 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, alveolitis allergic, dyspnoea exertional, eosinophil percentage increased, hypovolaemia, lung infiltration, lymphocyte percentage decreased, neutrophil percentage decreased, oxygen saturation decreased. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with PREDNISONE, DIGOXIN, HYDROCHLOROTHIAZIDE, MEDROXYPROGESTERONE, ESTRADIOL. Patient recovered.

Imatinib Side Effects Report #5202373-9
Imatinib side effect was reported by a Health Professional from SPAIN on Jan 03, 2007. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, disease progression, epidermal necrosis, excessive granulation tissue, hyperplasia, lividity, lung infiltration, oedema peripheral, parakeratosis. Imatinib dosage: 100 TO 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE, HYDROXYUREA. Patient died on 05/01/2003.


Imatinib Side Effects Report #5213542-6
Imatinib side effect was reported by a Health Professional from SPAIN on Jan 15, 2007. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, disease progression, epidermal necrosis, excessive granulation tissue, hyperplasia, lividity, lung infiltration, oedema peripheral, parakeratosis. Imatinib dosage: 100 TO 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE, HYDROXYUREA. Patient died on 05/01/2003.

Imatinib Side Effects Report #5441343-2
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Female patient, 49 years of age, weighting 163.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: lung infiltration. Imatinib dosage: 400 MG, QD. During the same period patient was treated with IMATINIB MESYLATE, PREDNISONE, PANTOPRAZOLE, DILTIAZEM, LEVOTHYROXINE, AZATHIOPRINE, ZOLPIDEM TARTRATE. Patient recovered.

Imatinib Side Effects Report #6066209-9
Imatinib side effect was reported by a Health Professional from AUSTRALIA on Jan 29, 2009. Male patient, 45 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, brain injury, cardio-respiratory arrest, dyspnoea, hyperphosphataemia, lung infiltration, pyrexia, renal failure acute, tumour lysis syndrome. Imatinib dosage: 400 MG DAILY. During the same period patient was treated with HYDROXYUREA, ALLOPURINOL, LEUKOPHERESIS. Patient died.

Imatinib Side Effects Report #6114749-6
Imatinib side effect was reported by a Health Professional from AUSTRALIA on Mar 10, 2009. Male patient, 45 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, brain injury, cardio-respiratory arrest, dyspnoea, hyperphosphataemia, lung infiltration, pyrexia, renal failure acute, tumour lysis syndrome. Imatinib dosage: 400 MG DAILY. During the same period patient was treated with HYDROXYUREA, ALLOPURINOL, LEUKOPHERESIS. Patient died.

Imatinib Side Effects Report #5140324-6
Imatinib side effect was reported by a Physician from on Oct 17, 2006. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: cough, lung infiltration, mucormycosis, pyrexia. Imatinib dosage: 600 MG, QD. During the same period patient was treated with PTK. Patient was hospitalized. Patient recovered.


Imatinib Side Effects Report #5141618-0
Imatinib side effect was reported by a Physician from on Oct 17, 2006. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: cough, lung infiltration, mucormycosis, pyrexia. Imatinib dosage: 600 MG, QD. During the same period patient was treated with PTK. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #4578148-0
Imatinib side effect was reported by a Physician from on Jan 28, 2005. Male patient, 32 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, lung infiltration, platelet count decreased, pulmonary haemorrhage. Imatinib dosage: unknown. Patient died.

Imatinib Side Effects Report #4606003-6
Imatinib side effect was reported by a Physician from on Jan 28, 2005. Male patient, 32 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, chest pain , dyspnoea, haemoptysis, lung infiltration, pulmonary haemorrhage. Imatinib dosage: 600 MG, QD. Patient died on 02/07/2003.